Miki Katoh

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Childhood Cancer

Walled Carbon Nanotubes

Venous Thromboembolism

Squamous Cell Carcinoma

Top Venues

Xenobiotica; the fate of foreign compounds in biological systems

Biopharmaceutics & drug disposition

This page only lists publications with an associated author ORCID identifier.

Publications

Ayaka Kojima, Masayuki Nadai, Norie Murayama, Hiroshi Yamazaki, Miki Katoh
Effects of tyrosine kinase inhibitors used for the treatment of non-small cell lung carcinoma on cytochrome P450 2J2 activities. Xenobiotica; the fate of foreign compounds in biological systems (2024)
Ayaka Kojima, Masayuki Nadai, Norie Murayama, Hiroshi Yamazaki, Miki Katoh
Effects of tyrosine kinase inhibitors used for the treatment of non-small cell lung carcinoma on cytochrome P450 2J2 activities. Xenobiotica; the fate of foreign compounds in biological systems (2024)
Yukiko Sakakibara, Ayaka Kojima, Yuki Asai, Masayuki Nadai, Miki Katoh
Changes in uridine 5'-diphospho-glucuronosyltransferase 1A6 expression by histone deacetylase inhibitor valproic acid. Biopharmaceutics & drug disposition 43 (5) (2022)
Ayaka Kojima, Masayuki Nadai, Norie Murayama, Hiroshi Yamazaki, Miki Katoh
Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2. Xenobiotica; the fate of foreign compounds in biological systems 52 (7) (2022)
Yuki Asai, Yukiko Sakakibara, Rina Inoue, Rikako Inoue, Masayuki Nadai, Miki Katoh
Effect of single-walled carbon nanotubes on cytochrome P450 activity in human liver microsomes in vitro. Biopharmaceutics & drug disposition 39 (5) (2018)
Yuki Asai, Hatsuna Tanaka, Masayuki Nadai, Miki Katoh
Effect of status epilepticus on expression of brain UDP-glucuronosyltransferase 1a in rats. Biopharmaceutics & drug disposition 39 (2) (2017)